Linda Lam

Phase 1/2 study of fractionated dose lutetium‐177–labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 ( ¹⁷⁷ Lu‐J591) for metastatic castration‐resistant prostate cancer

Scott T. Tagawa, Shankar Vallabhajosula, Paul J. Christos et al. · Cancer · 2019 · 131 citations · Full text

Saturation of, and competition for entry into, the apical secretory pathway

Alan D. Marmorstein, Karl G. Csaky, Judit Baffi et al. · Proceedings of the National Academy of Sciences · 2000 · 56 citations · Full text

Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia

Gail J. Roboz, Ellen K. Ritchie, Yulia Dault et al. · Haematologica · 2018 · 49 citations · Full text

Metal Chelates as Reversible Stains for Detection of Electroblotted Proteins: Application to Protein Microsequencing and Immunoblotting

Wayne F. Patton, Linda Lam, Qing Su et al. · Analytical Biochemistry · 1994 · 40 citations · Full text

Bioorganic Chemistry, Molecular Biology, Chemical Biology +21

Differential cellular responses induced by dorsomorphin and <scp>LDN</scp>‐193189 in chemotherapy‐sensitive and chemotherapy‐resistant human epithelial ovarian cancer cells

Jennifer L. Ali, Brittany J. Lagasse, Ainsley J. Minuk et al. · International Journal of Cancer · 2014 · 37 citations

Differential Cellular Responses, Eoc Cell Lines, Oncology +11